{"id":8155,"date":"2024-05-14T09:00:22","date_gmt":"2024-05-14T01:00:22","guid":{"rendered":"https:\/\/asiamd.com\/?p=8155"},"modified":"2025-08-20T11:49:51","modified_gmt":"2025-08-20T11:49:51","slug":"keyhole-surgery-for-liver-cancer","status":"publish","type":"post","link":"https:\/\/asiamd.bqubetech.com\/id\/2024\/05\/14\/keyhole-surgery-for-liver-cancer\/","title":{"rendered":"Keyhole Surgery for Liver Cancer"},"content":{"rendered":"<p style=\"text-align: left;\"><i><span style=\"font-weight: 400;\">This article has been fact-checked by <a href=\"https:\/\/asiamd.bqubetech.com\/make-an-appointment\/?dr=lee_lip_seng\">Dr Lee Lip Seng<\/a>, general surgeon at LS Lee Surgery,\u00a0 Mount Elizabeth Novena Specialist Centre, Singapore.<\/span><\/i><br \/>\n<a href=\"https:\/\/asiamd.bqubetech.com\/doctors\/lee-lip-seng\/\">About the Doctor<\/a><\/p>\n<p><span style=\"font-weight: 400;\">Keyhole surgery, also known as laparoscopic surgery, is a minimally invasive surgical <\/span><span style=\"font-weight: 400;\">technique used in various medical fields, including the treatment of liver cancer. This <\/span><span style=\"font-weight: 400;\">article explores the diagnosis of liver tumors, criteria for surgical removal, treatment <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">modalities for liver cancer, and the specific benefits of laparoscopic surgery.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<blockquote>\n<p class=\"p1\"><a href=\"https:\/\/bit.ly\/AsiaMDWhatsAppEN\" target=\"_blank\" rel=\"noopener\"><b><i>Follow us on WhatsApp for the latest updates: https:\/\/bit.ly\/AsiaMDWhatsAppEN\u00a0<\/i><\/b><\/a><\/p>\n<\/blockquote>\n<h2><\/h2>\n<h2><span style=\"font-weight: 400;\">1.\u00a0 <\/span><span style=\"font-weight: 400;\">Liver Tumor: Benign or Malignant?<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Determining whether a liver tumor is benign or malignant is crucial for guiding treatment <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">strategies. The diagnosis involves a combination of <\/span><span style=\"font-weight: 400;\">i<\/span><span style=\"font-weight: 400;\">maging studies, blood tests, <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">presence of risk factors for liver cancer and biopsy. <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(a) Imaging Studies\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Imaging modalities such as ultrasound, computed tomography (CT), and magnetic <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">resonance imaging (MRI) are the first steps in evaluating liver lesions. These <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">techniques help in assessing the size, location, and characteristics of the tumor, <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">providing valuable clues about its nature.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(b) Biopsy\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">A biopsy involves extracting a small tissue sample from the liver tumor under the <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">guidance of imaging techniques. The sample is then examined under a microscope to <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">determine the presence of cancer cells. This method is considered the gold standard for <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">diagnosing liver cancer. However, this is not always performed due to the risk of tumor <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">seedings and the spread of cancer when the biopsy is performed.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(c) Blood Tests\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Blood tests, including the measurement of alpha-fetoprotein (AFP) levels, can support <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">the diagnosis of liver cancer. Elevated AFP levels are often associated with <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">hepatocellular carcinoma (HCC), the most common type of liver cancer. On the other <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">hand, patients with cancer spread from the colon to the liver commonly have raised <\/span><span style=\"font-weight: 400;\">carcinoembryonic antigen (CEA).\u00a0<\/span><\/p>\n<p><strong>(d) Risk Factors\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The risk factors for liver cancer (HCC) include any conditions that can cause liver scarring or hardening resulting in liver cirrhosis (e.g. Hepatitis B infection, alcoholic liver cirrhosis and fatty liver).\u00a0<\/span><\/p>\n<h2><\/h2>\n<h2><span style=\"font-weight: 400;\">2. <\/span><span style=\"font-weight: 400;\">Criteria for Surgical Removal in Liver Cancer<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The selection of liver cancer patients for surgical removal is a critical and highly specific <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">process, influenced by a detailed assessment of the cancer&#8217;s characteristics, the patient&#8217;s <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">overall liver function, and the presence or absence of metastasis. Below are the refined <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">criteria focusing explicitly on liver cancer:<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(a) Type and Stage of Cancer\u00a0<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Hepatocellular Carcinoma (HCC): Surgical resection is commonly considered for <\/span><span style=\"font-weight: 400;\">patients with early-stage HCC. This is because early-stage HCC is often <\/span><span style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">localized and can be completely removed with surgery.<\/span><\/span><\/li>\n<li><span style=\"font-weight: 400;\">Metastatic Liver Cancer: In certain cases where the liver cancer has originated <\/span><span style=\"font-weight: 400;\">from another primary site (metastatic liver cancer), surgery might still be an <\/span><span style=\"font-weight: 400;\">option if the cancer is limited to a few small areas in the liver and the primary <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">cancer is under control.<\/span><\/li>\n<\/ul>\n<p><strong>(b) Liver Function\u00a0<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Adequate Liver Reserve: Successful liver surgery requires remaining liver tissue <\/span><span style=\"font-weight: 400;\">to be sufficient to support life. This is often assessed using the Child-Pugh score, <\/span><span style=\"font-weight: 400;\">which evaluates liver function based on total bilirubin, serum albumin levels, <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">prothrombin time, the presence of ascites, and encephalopathy. Only patients <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">with good liver function (Child-Pugh A) are typically considered for surgery.<\/span> <span style=\"font-weight: 400;\">Adequate liver reserve requires both good liver function and adequate future liver <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">remnant (i.e. adequate remnant liver volume after resection)<\/span><\/li>\n<\/ul>\n<p><strong>(c) Tumor Size and Location\u00a0<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Operable Tumors: Successful tumor resection needs to ensure cancer is <\/span><span style=\"font-weight: 400;\">removed completely and the patient still has adequate future liver remnant. <\/span><span style=\"font-weight: 400;\">Patients with no liver cirrhosis and good liver function can survive even with only <\/span><span style=\"font-weight: 400;\">30% of future liver remnant.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Vascular Invasion: The absence of major vascular invasion (e.g. involvement of <\/span><span style=\"font-weight: 400;\">the main portal vein, hepatic artery or inferior vena cava) is crucial. Tumors that <\/span><span style=\"font-weight: 400;\">encase or invade major blood vessels are often deemed inoperable due to the <\/span><span style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">higher risk of complications.<\/span><\/span><\/li>\n<\/ul>\n<p><strong>(d) Absence of Widespread Disease\u00a0<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Localized Disease: Surgery is considered most effective for patients whose <\/span><span style=\"font-weight: 400;\">cancer has not spread beyond the liver. This determination is typically made <\/span><span style=\"font-weight: 400;\">using advanced imaging techniques, such as PET scans or CT scans. These <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">scans help to ensure that there is no distant metastasis, which would generally <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">preclude the benefit of surgical removal of the liver tumor.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/li>\n<\/ul>\n<h2><\/h2>\n<h2><span style=\"font-weight: 400;\">3. <\/span><span style=\"font-weight: 400;\">Treatment Modalities for Liver Cancer<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Liver cancer, including primary forms such as hepatocellular carcinoma (HCC) and <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">secondary (metastatic) cancers, requires a multifaceted approach to treatment. The <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">choice of therapy depends on several factors, including the stage of the cancer, the <\/span><span style=\"font-weight: 400;\">overall liver function, and the health status of the patient. Here is a more detailed look at <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">the treatment options specifically tailored for liver cancer:<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(a) Surgical Resection\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">This involves the surgical removal of the cancerous part of the liver. It is most effective <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">in patients with localized tumors and good liver function, without significant cirrhosis or <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">other liver diseases. Resection is considered curative for small, well-defined tumors that <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">have not invaded blood vessels or spread outside the liver.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(b) Liver Transplantation\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Transplantation offers hope for patients with early-stage liver cancer who have severe <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">liver dysfunction, typically due to underlying cirrhosis. The criteria for transplantation in <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">liver cancer patients include the UCSF criteria. This approach aims to remove all <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">cancerous cells and replace the liver with a healthy one, potentially curing the cancer <\/span><span style=\"font-weight: 400;\">and the liver disease.\u00a0<\/span><\/p>\n<p><strong>(c) Ablation Therapy\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Ablation destroys liver tumors without removing them. Techniques like radiofrequency <\/span><span style=\"font-weight: 400;\">ablation (RFA) and microwave ablation (MWA) use heat to kill cancer cells. Ablation is\u00a0<\/span><span style=\"font-weight: 400;\">suitable for patients with small tumors (typically less than 3 cm) who may not be <\/span><span style=\"font-weight: 400;\">candidates for surgery due to their location within the liver or because of poor liver <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">function.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(d) Embolization Therapy\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">This method targets tumors&#8217; blood supply, essential for their growth and survival. <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">Transarterial chemoembolization (TACE) combines embolization with chemotherapy, <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">directly delivering cancer-fighting drugs to the liver tumor and blocking its blood supply. <\/span><span style=\"font-weight: 400;\">Another form, radioembolization (Y90), uses tiny radioactive beads to deliver radiation <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">directly to the tumor. These approaches are beneficial for controlling tumor growth, <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">especially in cases where surgery is not feasible.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(e) Targeted Therapy and Immunotherapy\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Targeted therapies act on specific molecular targets associated with cancer cells, such <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">as sorafenib, which is approved for advanced HCC. These drugs can stop the growth <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">and spread of cancer cells while minimizing damage to healthy cells. Immunotherapy, <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">like the checkpoint inhibitors nivolumab and pembrolizumab, boosts the body&#8217;s immune <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">system to fight cancer. These treatments are options for advanced liver cancer, <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">often used when the cancer has not responded to other treatments.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(f) Chemotherapy\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Traditional chemotherapy, which uses drugs to kill cancer cells, has a limited role in <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">treating liver cancer due to its effectiveness and the potential for liver damage. <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">However, hepatic artery infusion (HAI) chemotherapy delivers chemotherapy drugs <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">directly into the liver, targeting cancer cells more precisely and reducing systemic side <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">effects. This technique may be used for advanced liver cancer or when other treatments <\/span><span style=\"font-weight: 400;\">are not suitable.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Each of these treatments has its benefits and potential risks, and the best approach <\/span><span style=\"font-weight: 400;\">depends on individual patient factors. A multidisciplinary team of specialists, including <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">hepatologists, oncologists, and surgeons, typically collaborates to create a personalized <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">treatment plan for each patient with liver cancer.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<h2><\/h2>\n<h2><span style=\"font-weight: 400;\">4. <\/span><span style=\"font-weight: 400;\">Benefits of Laparoscopic Surgery for Liver Cancer<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Laparoscopic surgery, specifically tailored for the treatment of liver cancer, provides a <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">range of advantages when compared to the traditional open hepatectomy.\u00a0<\/span><\/p>\n<p><strong>(a) Enhanced Recovery and Reduced Postoperative Discomfort\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Laparoscopic liver surgery involves making several small incisions rather than one large <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">opening. This minimally invasive approach causes less post-operative pain, faster <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">recovery, use less analgesia and minimise the risk of medication-related side effects. <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(b) Minimized Hospital Stay Duration\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">One of the most immediate benefits observed with laparoscopic liver surgery is the <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">reduced length of hospital stay. Since the procedure is less invasive, patients recover <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">more quickly and are discharged earlier, thereby reducing potential hospital-acquired <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">infections.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>\u00a0(c) Decreased Risk of Surgical Complications\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The magnification provided by laparoscopic instruments allows for better visualisation <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">and precision, with lower potential risk of complications such as bleeding, infections and <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">incisional hernias associated with larger incisions in open surgery.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><strong>(d) Superior Cosmetic Results\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Given that liver cancer surgery can be a major procedure, the prospect of minimal <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">scarring is a significant advantage. Laparoscopic surgery for liver cancer uses small <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">incisions, typically no more than a few centimeters in length, which result in minimal <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">scarring. This aspect is particularly valued by patients, as it lessens the physical <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">reminders of their surgery and cancer experience, contributing positively to <\/span><span style=\"font-weight: 400;\">emotional and psychological recovery.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Keyhole surgery, also known as laparoscopic surgery, is a minimally invasive surgical technique used in various medical fields, including the treatment of liver cancer.<\/p>\n","protected":false},"author":9,"featured_media":8156,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","footnotes":""},"categories":[119,168],"tags":[333,557,708,717,718,1553,1584,1637,1729,1732,1736,1771],"class_list":["post-8155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-surgery","category-liver","tag-cancer","tag-general-surgery","tag-laparoscopic-surgery","tag-liver-and-gallbladder","tag-liver-cancer","tag-1553","tag-1584","tag-1637","tag-1729","tag-1732","tag-1736","tag-1771"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"id","enabled_languages":["en","zh","ko","ja","mn","vi","ta","th","ms","km","id","my","hi"],"languages":{"en":{"title":true,"content":true,"excerpt":true},"zh":{"title":true,"content":true,"excerpt":true},"ko":{"title":false,"content":false,"excerpt":false},"ja":{"title":false,"content":false,"excerpt":false},"mn":{"title":false,"content":false,"excerpt":false},"vi":{"title":false,"content":false,"excerpt":false},"ta":{"title":false,"content":false,"excerpt":false},"th":{"title":false,"content":false,"excerpt":false},"ms":{"title":false,"content":false,"excerpt":false},"km":{"title":false,"content":false,"excerpt":false},"id":{"title":false,"content":false,"excerpt":false},"my":{"title":false,"content":false,"excerpt":false},"hi":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/posts\/8155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/comments?post=8155"}],"version-history":[{"count":4,"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/posts\/8155\/revisions"}],"predecessor-version":[{"id":10252,"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/posts\/8155\/revisions\/10252"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/media\/8156"}],"wp:attachment":[{"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/media?parent=8155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/categories?post=8155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asiamd.bqubetech.com\/id\/wp-json\/wp\/v2\/tags?post=8155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}